Skip to content

A Prospective Investigation on the Safety and Feasibility of the investigative endoscopic system in the visualization of the upper digestive tract and facilitation of tool delivery for diagnostic or therapeutic interventions.

Robotic-AssistEd Trans-Oral GastrointestiNal (GI) Assessment ProspecTive Evaluation: The RESONATE Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12625000868482
Acronym
RESONATE study
Enrollment
28
Registered
2025-08-11
Start date
2025-07-06
Completion date
2025-07-21
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This is a single-centre safety and feasibility study of a new device designed for the visualization of the upper digestive tract and facilitation of tool delivery for diagnostic or therapeutic interventions. Subjects will undergo a procedure with a new device designed to assist qualified physicians to navigate a GI endoscope and endoscopic tools in the upper GI tract using endoscopic visualization for observation, diagnostic procedures, and/or endoscopic treatment. These subjects will be followed up to 30 days post-procedure as per standard of care. This is not a powered study, so there is no formal hypothesis. This research is an early feasibility study and will determine whether use of this new system is safe and feasible.

Interventions

The purpose of this research study is to assess the safety and feasibility of a new device designed for the visualization of the upper digestive tract and facilitation of tool delivery for diagnostic or therapeutic interventions. Subjects will undergo a procedure with a device which is a software- controlled, electro-mechanical system designed to assist qualified physicians to navigate a GI endoscope and endoscopic tools in the upper GI tract using endoscopic visualization for observation, diagn

The purpose of this research study is to assess the safety and feasibility of a new device designed for the visualization of the upper digestive tract and facilitation of tool delivery for diagnostic or therapeutic interventions. Subjects will undergo a procedure with a device which is a software- controlled, electro-mechanical system designed to assist qualified physicians to navigate a GI endoscope and endoscopic tools in the upper GI tract using endoscopic visualization for observation, diagnostic procedures, and/or endoscopic treatment. The device is similar to a conventional endoscopy; the investigational device will be inserted through the mouth and navigated into the upper GI tract. Procedures will occur in an endoscopy theatre and will be performed by qualified physicians. Procedures may be performed under general anesthesia or moderate sedation. Patients will be informed of the anesthesia method prior to the procedure. The study procedure will last for approximately 60 minutes. Patients will be monitored in the hospital post-procedure and prior to discharge and will complete one follow-up visit via clinic visit or telehealth within 30 days of the procedure. Follow up is in accordance with the follow-up practice for this procedure without an investigational device and will involve the study doctor asking the patient whether they experienced any adverse events including any hospitalizations. Patients can also self-monitor themselves and in the event of a suspected complication, they can contact the study team. Strategies used to assess adherence to the intervention include photo documentation of the access to landmarks in the upper GI tract in the same manner as standard EGD or other endoscopy procedures.

Sponsors

Ascend Clinical Research Organisation, Pty Ltd.
Lead SponsorCommercial sector/Industry

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
22 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Subject is greater than or equal to 22 years old and less than 80 years old at the time consent. 2. Subject is suitable for and is planned to undergo an elective outpatient EGD procedure according to local guidelines

Exclusion criteria

1. Subjects for whom routine EGD procedures are contraindicated due to comorbid medical conditions per GESA/ASGE guidelines 2. Subjects with American Society of Anesthesiologists (ASA) classification greater than or equal to 4. 3. Subjects with clinically significant acute GI pathology such as acute GI bleeding (variceal and non-variceal), inability to swallow liquids or solids or other pathology as assessed by the Investigator 4. Women of child-bearing potential must not be pregnant as confirmed with a negative urine or serum beta human chorionic gonadotropin test no more than 24 hours prior to the index procedure

Outcome results

None listed

Source: ANZCTR · Data processed: Apr 17, 2026